For these reasons, interventions centred in nutrition and exercise training, alongside SGLT2 inhibitors, can potentially improve the quality of life of HFpEF patients with associated frailty and sarcopenia [13, 58, 62, 63]. This evidence concerns the gene SLC5A2 and sarcopenia.